These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2467596)

  • 1. Progress in the development of competitive bombesin antagonists.
    Coy DH; Heinz-Erian P; Jiang NY; Taylor J; Moreau JP; Gardner JD; Jensen RT
    Ann N Y Acad Sci; 1988; 547():150-7. PubMed ID: 2467596
    [No Abstract]   [Full Text] [Related]  

  • 2. [D-Phe12]bombesin analogues: a new class of bombesin receptor antagonists.
    Heinz-Erian P; Coy DH; Tamura M; Jones SW; Gardner JD; Jensen RT
    Am J Physiol; 1987 Mar; 252(3 Pt 1):G439-42. PubMed ID: 2435173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent bombesin receptor antagonists distinguish receptor subtypes.
    von Schrenck T; Wang LH; Coy DH; Villanueva ML; Mantey S; Jensen RT
    Am J Physiol; 1990 Sep; 259(3 Pt 1):G468-73. PubMed ID: 2169207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists.
    Wang LH; Coy DH; Taylor JE; Jiang NY; Moreau JP; Huang SC; Frucht H; Haffar BM; Jensen RT
    J Biol Chem; 1990 Sep; 265(26):15695-703. PubMed ID: 1697594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (D-Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists.
    Merali Z; Merchant CA; Crawley JN; Coy DH; Heinz-Erian P; Jensen RT; Moody TW
    Synapse; 1988; 2(3):282-7. PubMed ID: 2463692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bombesin binding and biological effects on pancreatic acinar AR42J cells.
    Logsdon CD; Zhang JC; Guthrie J; Vigna S; Williams JA
    Biochem Biophys Res Commun; 1987 Apr; 144(1):463-8. PubMed ID: 2437913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analogue of substance P with broad receptor antagonist activity.
    Zhang L; Mantey S; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1988 Oct; 972(1):37-44. PubMed ID: 2460143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antagonism of bombesin in the CNS by substance P analogues.
    Yachnis AT; Crawley JN; Jensen RT; McGrane MM; Moody TW
    Life Sci; 1984 Nov; 35(19):1963-9. PubMed ID: 6208451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformation studies on bombesin receptor antagonists: 500 MHz NMR and CD characterization of synthetic (D-Phe12, Leu14)-bombesin.
    Di Bello C; Scanelli A; Corradini MG; Paolillo L; Trivellone E; Scatturin A; Vertuani G; Gozzini L; de Castiglione R
    Biochem Biophys Res Commun; 1989 Jun; 161(3):987-93. PubMed ID: 2545203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed loci of interaction between bombesin and its receptor.
    Tritsch GL
    J Mol Recognit; 1991; 4(2-3):53-6. PubMed ID: 1667264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The trophic effect of beta-amyloid 25-35 peptide is not mediated by NK1 or bombesin receptors.
    Burgevin MC; Daniel N; Doble A; Blanchard JC
    Neuroreport; 1992 Dec; 3(12):1131-4. PubMed ID: 1283535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bombesin receptor antagonists [corrected]. 1. Analogues with deleted, inverted or substituted amino acid residues.
    De Castiglione R; Gozzini L; Mena R; Brugnolotti M; Ciomei M; Molinari I; Comoglio PM; Gaudino G
    Farmaco; 1990 Dec; 45(12):1251-63. PubMed ID: 1965286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homodimeric forms of bombesin act as potent antagonists of bombesin on Swiss 3T3 cells.
    Gawlak SL; Kiener PA; Braslawsky GR; Greenfield RS
    Growth Factors; 1991; 5(2):159-70. PubMed ID: 1662974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor heterogeneity for bombesin-like peptides in the rat central nervous system.
    Ladenheim EE; Jensen RT; Mantey SA; McHugh PR; Moran TH
    Brain Res; 1990 Dec; 537(1-2):233-40. PubMed ID: 1964836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of bombesin and related peptides with receptors on pancreatic acinar cells.
    Jensen RT; Coy DH; Saeed ZA; Heinz-Erian P; Mantey S; Gardner JD
    Ann N Y Acad Sci; 1988; 547():138-49. PubMed ID: 2467595
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of ability of various substance P antagonists to inhibit action of bombesin.
    Jensen RT; Heinz-Erian P; Mantey S; Jones SW; Gardner JD
    Am J Physiol; 1988 Jun; 254(6 Pt 1):G883-90. PubMed ID: 2454035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of [Leu-13-psi-CH2NH-Leu14]-bombesin as a specific bombesin receptor antagonist on isolated smooth muscle cells.
    Severi C; Coy DH; Jensen RT; Boschero L; Anania MC; Delle Fave G
    J Pharmacol Exp Ther; 1989 Nov; 251(2):713-7. PubMed ID: 2478696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bombesin receptor antagonists: different classes and cellular basis of action.
    Jensen RT; Mrozinski JE; Coy DH
    Recent Results Cancer Res; 1993; 129():87-113. PubMed ID: 8394597
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of substitutions in position 12 of bombesin on antagonist activity.
    Saeed ZA; Huang SC; Coy DH; Jiang NY; Heinz-Erian P; Mantey S; Gardner JD; Jensen RT
    Peptides; 1989; 10(3):597-603. PubMed ID: 2476788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.